C o p y r i g h t © 2 0 1 3 , S A S I n s t i t u t e I n c . A l l r i g h t s r e s e r v e d .
TRANSFORMING LIFE SCIENCES
THROUGH ENTERPRISE ANALYTICS
HOW ANALYTICS SOLUTIONS AND ENTERPRISE ENVIRONMENTS ARE IMPROVING
EFFICIENCY AND ENABLING NEW INSIGHTS THROUGHOUT THE LIFE SCIENCES INDUSTRY
Matt Gross
Director
Health and Life Sciences Global Practice
SAS Institute
[email protected]
C o p y r i g h t © 2 0 1 3 , S A S I n s t i t u t e I n c . A l l r i g h t s r e s e r v e d .
歓迎
C o p y r i g h t © 2 0 1 3 , S A S I n s t i t u t e I n c . A l l r i g h t s r e s e r v e d .
LIFE SCIENCES
HISTORICAL CHALLENGES
Research
Development
Production
Marketing
Regulation
Research
Development
Production
Marketing
Regulation
C o p y r i g h t © 2 0 1 3 , S A S I n s t i t u t e I n c . A l l r i g h t s r e s e r v e d .LIFE SCIENCES
THE BUSINESS OF CLINICAL RESEARCH
Drug Discovery
Drug Development
C o p y r i g h t © 2 0 1 3 , S A S I n s t i t u t e I n c . A l l r i g h t s r e s e r v e d .
ANALYTIC
OPPORTUNITIES
INSIGHT THROUGHOUT THE PROCESS
Drug
Discovery
Drug
Development
Marketing
and
Business
Development
Sales
Manufacturing
Supply Chain
Operations
Business
IT
Biomarkers &
x-omics
Visualization
Modeling /
Simulation
Analytic
Analysis
Visualization
Modeling /
Simulation
Analytic
Analysis
Recruitment /
Retention
Portfolio
Optimization
Data
Integration
Performance
Management
Master Data
Management
Scalable
Analytics
Platform
Enterprise
Workflow
Social Media
Analytics
Pharmaco-vigilance
Aggregate
Spend
Compliance
Managed
Market
Analysis
Marketing
Operations
Sales Force
Optimization
Demand Driven
Forecasting
Customer
Intelligence
Targeting and
Segmentation
Campaign
Management
Production
Quality
Process
Management
Workforce
Optimization
Demand Driven
Forecasting
Quality by
Design
Real World
Data Analysis
Supply
Planning
Demand
Planning
Materials
Management
Vendor
Management
Fraud
Management
Risk
Management
Activity Based
Management
Compliance
Reporting
Portfolio
Optimization
Enterprise
Workflow
C o p y r i g h t © 2 0 1 3 , S A S I n s t i t u t e I n c . A l l r i g h t s r e s e r v e d .Commercial
LIFE SCIENCES
PROCESS OVERVIEW
Clinical R&D
Data
Insight
Strategy
Dialogue
Reporting
Integration
Transformation
Analysis
Reporting
Submission
Company Confidential - For Internal Use Only
Copyright © 2012, SAS Institute Inc. All rights reserved.
HLS OFFERINGS
2013 CURRENT
Available
Life Sciences
Health Care
Clinical R&D
Commercial
Payer
Provider
Drug Development
Clinical Data Integration with
Medidata Rave Adapter
JMP Clinical
Clinical Standards Toolkit
Fraud Framework for Health
Care
JMP Genomics
Social Media Analytics for Life
Sciences
Physician Targeting
Global Aggregate Spend
Market Mix Advisor
Marketing Operations
Management
Demand Driven Forecasting
Health Care Cost Analytics
Health and Condition
Management
Managed Care Rebate
Optimization
ECR Analytics
Revision 2013.04.08.1430
Company Confidential - For Internal Use Only
Copyright © 2012, SAS Institute Inc. All rights reserved.
HLS OFFERINGS
2013 CURRENT AND PROPOSED
Available
In Development
Life Sciences
Health Care
Clinical R&D
Commercial
Payer
Provider
Drug Development
Clinical Data Integration with
Medidata Rave Adapter
JMP Clinical
Clinical Standards Toolkit
Fraud Framework for Health
Care
Health Outcomes Analysis
Metadata / Standards
Management
Clinical Trial Optimization
Risk-Based Monitoring
JMP Genomics
Trial Recruitment and
Simulation
Safety / Signal Detection
Social Media Analytics for Life
Sciences
Physician Targeting
Global Aggregate Spend
Market Mix Advisor
Marketing Operations
Management
Demand Driven Forecasting
Global Launch Sequence
Optimization
Health Care Cost Analytics
Member Portfolio Optimization
Population Health Insight
All-Payers Claim Database
Quality Measure Forecasting
Health and Condition
Management
Global Trigger Tool / Patient
Safety
Risk Adjustor Maximization
Visual Analytics for Life Sciences
Visual Analytics for Health Care
Financial Risk Analytics
Population Health Insight
Managed Care Rebate
Optimization
Customer Analytics &
Engagement
ECR Analytics
C o p y r i g h t © 2 0 1 3 , S A S I n s t i t u t e I n c . A l l r i g h t s r e s e r v e d .
DRUG DEVELOPMENT
ANALYTIC
OPPORTUNITIES
CLINICAL RESEARCH AND DEVELOPMENT
INTEGRATION
TRANSFORMATION
ANALYSIS
REPORTING
POST SUBMISSION
SUBMISSION
EHR / HIE / RWD
LAB
IVRS
CDS
AERS
AE ANALYSIS
STATISTICAL
REPORT(S)
SAFETY
REPORT(S)
ANALYSIS
DATA SETS
READY FOR
SUBM
ISSION
ERP
Legacy
PUBLICATIONS
THERAPEUTIC
INSIGHT
TRIAL DESIGN &
PLANNING
NEW
MARKETING
CLAIMS
Safety
ODS
RAW DATA
SETS
Content
Repository
SUBMISSION
DATA SETS
Imaging
ePRO
Social Media
Staging
Integration
Transformation
Analysis
Reporting
Submission
Post-Submission
DATA INTEGRATION /
DATA QUALITY
INDUSTRY VALIDATION /
STANDARDIZATION
PATIENT SAFETY /
PHARMACOVIGILANCE
CLINICAL TRIAL
ANALYSIS /
EXPLORATION
C o p y r i g h t © 2 0 1 3 , S A S I n s t i t u t e I n c . A l l r i g h t s r e s e r v e d .DRUG DEVELOPMENT
SAS CLINICAL DATA INTEGRATION
SAS DRUG DEVELOPMENT
JMP CLINICAL
EDC ADAPTERS
(e.g. RAVE)
ANALYTIC
OPPORTUNITIES
CLINICAL RESEARCH AND DEVELOPMENT
INTEGRATION
TRANSFORMATION
ANALYSIS
REPORTING
POST SUBMISSION
SUBMISSION
EHR / HIE / RWD
LAB
IVRS
CDS
AERS
AE ANALYSIS
STATISTICAL
REPORT(S)
SAFETY
REPORT(S)
ANALYSIS
DATA SETS
READY FOR
SUBM
ISSION
ERP
Legacy
PUBLICATIONS
THERAPEUTIC
INSIGHT
TRIAL DESIGN &
PLANNING
NEW
MARKETING
CLAIMS
Safety
ODS
RAW DATA
SETS
Content
Repository
SUBMISSION
DATA SETS
Imaging
ePRO
Social Media
Staging
Integration
Transformation
Analysis
Reporting
Submission
Post-Submission
DATA INTEGRATION /
DATA QUALITY
INDUSTRY VALIDATION /
STANDARDIZATION
PHARMACOVIGILANCE
PATIENT SAFETY /
CLINICAL TRIAL
C o p y r i g h t © 2 0 1 3 , S A S I n s t i t u t e I n c . A l l r i g h t s r e s e r v e d .
ANALYTIC
OPPORTUNITIES
COMMERCIAL / SALES AND MARKETING
Data
Insight
Strategy
Dialogue
Reporting
C o p y r i g h t © 2 0 1 3 , S A S I n s t i t u t e I n c . A l l r i g h t s r e s e r v e d .
ANALYTIC
OPPORTUNITIES
COMMERCIAL / SALES AND MARKETING
SAS
®
SALES
FORECAST &
SIMULATION
SAS
®
MARKETING
MIX ADVISOR
SAS
®
PHYSICIAN TARGETING
SAS
®
MARKETING AUTOMATION
SAS
®
PHYSICIAN
TARGETING
SAS
®
SOCIAL MEDIA
ANALYTICS
SAS
®
SOCIAL MEDIA
ANALYTICS
Data
Insight
Strategy
Dialogue
Reporting
C o p y r i g h t © 2 0 1 3 , S A S I n s t i t u t e I n c . A l l r i g h t s r e s e r v e d .
ADVANCED
ANALYTICS
THE EVOLUTION OF ANALYTICS
OPTIMIZATION
PREDICTIVE MODELING
FORECASTING
STATISTICAL ANALYSIS
ALERTS
QUERY DRILLDOWN (OR OLAP)
AD HOC REPORTS
STANDARD REPORTS
6
7
8
1
2
3
4
5
C o p y r i g h t © 2 0 1 3 , S A S I n s t i t u t e I n c . A l l r i g h t s r e s e r v e d .ENTERPRISE
C o p y r i g h t © 2 0 1 3 , S A S I n s t i t u t e I n c . A l l r i g h t s r e s e r v e d .
ENTERPRISE
ANALYTICS
ENTERPRISE
ANALYTICS
FROM EXPLORATION TO OPTIMIZATION
C o p y r i g h t © 2 0 1 3 , S A S I n s t i t u t e I n c . A l l r i g h t s r e s e r v e d .
Comparative
effectiveness
•
Use of real world data
Need new methods of
innovation requiring
access to knowledge
and information both
internally and
externally
Effective collaboration
with external stakeholders
and partners
•
Improve agility
•
Quicker response to
change
Increasingly complex clinical
protocols
•
Exponential increase in
data collected
Increase revenue
•
Rising costs
•
Depleted pipelines
•
Impending patent
expiries
ENTERPRISE
ANALYTICS
C o p y r i g h t © 2 0 1 3 , S A S I n s t i t u t e I n c . A l l r i g h t s r e s e r v e d .ACCESSIBLE
ANALYTICS
ANALYTICS WHERE YOU NEED THEM
C o p y r i g h t © 2 0 1 3 , S A S I n s t i t u t e I n c . A l l r i g h t s r e s e r v e d .
MODERN DAY
CHALLENGES
REAL WORLD DATA, REGULATIONS AND RESOURCES
Unstructured Data
Social Media
Big Data
ePedigree
Real World Data
Challenges
Regulatory
Risk-based Monitoring
Analytically-skilled
Resources
C o p y r i g h t © 2 0 1 3 , S A S I n s t i t u t e I n c . A l l r i g h t s r e s e r v e d .
CURRENT
INITIATIVES
A SAMPLE OF ANALYTICS-DRIVEN INNOVATION
Data Transparency
Data Sharing
Data Veracity
C o p y r i g h t © 2 0 1 3 , S A S I n s t i t u t e I n c . A l l r i g h t s r e s e r v e d .
質問やコメント
QUESTIONS AND COMMENTS
C o p y r i g h t © 2 0 1 3 , S A S I n s t i t u t e I n c . A l l r i g h t s r e s e r v e d .
